The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of TQB2450 (PD-L1 blockade) plus anlotinib combined with oxaliplatin and capecitabine in the first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: A single-arm, multicenter phase II clinical trial.
 
Ning Li
No Relationships to Disclose
 
Wen-Ying Deng
No Relationships to Disclose
 
Yi-Jie Ma
No Relationships to Disclose
 
Liang-Yu Bie
No Relationships to Disclose
 
Chi Zhang
No Relationships to Disclose
 
Chen Wei
No Relationships to Disclose
 
Suxia Luo
No Relationships to Disclose